Time-averaged Hb thresholds associated with outcomes:
• <108 g/L: Increased all-cause mortality.
• <109 g/L: Higher MACE risk.
• <111 g/L: Higher MACE+ risk.
Fine-tuning anemia management is critical. #AnemiaInCKD

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | NEJM Intravenous iron is a standard treatment for patients undergoing hemodialysis, but comparative data regarding clinically effective regimens are limited. In a multicenter, open-label trial with blin...

💡 Takeaway: “Iron therapy = powerful ally for dialysis patients!”

🥨 www.nejm.org/doi/full/10....

#AnemiaInCKD #DialysisCare #NephrologyResearch